ABSTRACT The purpose of this study is to develop novel colon-specific drug delivery systems with pHsensitive swelling and drug release properties. Methacrylic-type polymeric prodrugs with different content levels of 5-amino salicylic acid (5-ASA) were synthesized by free radical copolymerization of metacrylic acid (MAA), polyethylene glycol monomethacrylate (PEGMA), and a methacrylic derivative of 5 -ASA (methacryloyloxyethyl 5 -amino salicylate [MOES]). The copolymers were characterized, and the drug content of the copolymers was determined. The effect of copolymer composition on the swelling behavior and hydrolytic degradation was studied in simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, p H 7.2). The swelling and hydrolytic behavior of the copolymers was dependent on the content of MAA groups and caused a decrease in gel swelling in SGF or an increase in gel swelling in SIF. Drug release studies showed that increasing content of MAA in the copolymer enhances the hydrolysis in SIF but has no effect in SGF. The results suggest that hydrogen-bonded complexes are formed between MAA and PEG pendant groups and that these pH-sensitive systems could be useful for preparation of a controlledrelease formulation of 5-ASA.
INTRODUCTION
Orally administered colonic delivery systems are difficult to design because of the anatomic location of the colon at the end of the alimentary canal. This presents a formidable challenge in targeting drugs specifically to this site for local absorption so that systemic absorption is reduced and painful treatments, such as enemas, can be avoided. Local treatment of inflammatory bowel disease, for example, would increase the efficiency of drugs used in its treatment, such as salicylic acid derivatives (eg, 5-amino salicylic acid and mesalazine).
Colonic azoreductase is used in a number of prodrugs, polymeric coatings, and cross-linked hydrogels [1] . These systems are aimed primarily at the specific release of 5-ASA in the colon. The interest in 5-ASA delivery systems stems from the successful use of sulfasalazine in the treatment of inflammatory bowel disease. Sulfasalazine is a combination of a salicylate and a sulfonamide linked by azo bonds. The recognition that 5 -ASA is the active moiety in mesalazine has led to the replacement of mesalazine by sulfapyridine as a carrier entity in 5-ASA therapy.
Another approach that can be used in colon-specific delivery is to attach 5-ASA via an azo bond to a polymeric carrier [2] [3] [4] . Advantages such as nonabsorption from the small intestine, elimination of sulfapyridine-produced side effects, and nonabsorption of the polymeric cleavage products were claimed for some of the water-soluble polymeric prodrugs containing 5 -ASA residue with azo linkage to the polymer backbone. Publications show that azo polymer-based colonic drug targeting presents some problems [5, 6] ; it seems that microbial degradation of the investigated azo polymers is slow. On the other hand, azo aromatic compounds include several substances that are known to be carcinogens [6] . A system that would protect the drugs from the gastric environment yet allow release and absorption in the colon would provide a significant advantage in colonspecific drug delivery. These requirements have prompted the development of polymeric systems that swell minimally under a cidic conditions but extensively in basic intestinal medium [7, 8] .
Responsive hydrogel networks consisting of polymethacrylic acid (PMAA) and polyethylene glycol (PEG) are classic examples of pH-sensitive carriers that exhibit swelling transitions in response to changes in pH [9, 10] . PEG and PMAA may be associated to form 2 hydrogen-bonded complexes under acidic conditions. A hydrogel containing a backbone of PMAA and grafts of PEG exhibits a relatively low degree of swelling under complex-promoting conditions (low pH when acid is protonated) and a high degree of swelling when the complex is broken (high p H when the acid is neutralized) [11] . Several hydrogel networks, including a PMAA backbone and PEG grafts, were synthesized and used to protect sensitive drugs from proteolytic degradation in the stomach and upper portion of the small intestine. In all cases, the drug was physically trapped in a polymer matrix, and drug release occurred via diffusion from the interconnected hydrogel matrix [12, 13] .
In the present study, the synthesis and swelling properties of poly (methacrylic acid-co-ethyleneglycol monomethoacrylate-co-methacryloyloxyethyl 5 -amino salicylate) (poly [MAA-co-EGMA-co-MOES]) are reported. A previous study reported on the synthesis and copolymerization of methacryloyloxyethyl 5 -amino salicylate (MOES) with methacrylic acid (MAA) (poly [MOES-co-MAA]) or hydroxyethyl methacrylate (HEMA) (poly [MOES-co-HEMA]) [14] . In this research, the synthesis of a pH-sensitive hydrogel network consisting of MOES, MAA, and polyethylene glycol monomethacrylate (PEGMA) is described. Complex-forming constituents of the hydrogel were covalently linked to each other and to the drug-linked monomer, and the swelling characteristics and drug release properties of the hydrogel were studied in simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, pH 7.2). 
MATERIALS AND METHODS

Chemicals
Synthesis of methacryloyloxyethyl 5 -amino salicylate (MOES)
A
Preparation and Properties of Copolymers
Drug-linked copolymers were synthesized by copolymerization of MAA, PEGMA, and MOES in a solution of methanol with a variable feed ratio as shown in Table 1 . Copolymerization was carried out in the presence of benzoyl peroxide as an initiator. Each mixture was stirred for 6 hours at 60°C under nitrogen. The copolymers obtained were precipitated with acetone, c entrifuged at 3000 rpm for 2 hours, and washed twice with a mixture of ethanol-acetone (1/1 vol/vol). 
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The copolymers were characterized by the content of aromatic ester (MOES) and carboxylic groups (MAA). The content of aromatic ester was determined by measuring UV absorbance at 240 nm. The content of 5-ASA pendant groups was determined by nitrogen analysis and an exhaustive hydrolysis method. The hydrolysis was performed in a dialysis tube at pH 10 and 70°C for 24 hours. The quantity of released drug was measured by means of a UV spectrophotometer (2100 Shimadzu, Kyoto, Japan). The results were compatible with each other. The carboxylic acid content of copolymers was determined according to the method described in the literature [10] . The molecular weight of polymers was measured by gel permeation chromatography (GPC) using a Waters model 150-C (Milford, MA) containing 4 Shodex GPC KF-800 series columns (SDK, Tokyo, Japan). DMF was used as the eluent at a flow rate of 1 mL/min. The column setting was calibrated by using well-characterized polyethylene oxide within the range of 2600 to 885 000 MW.
Measurement of Swelling Ratio
The hydrogels were characterized by the equilibrium swelling ratio. Dried copolymers were allowed to swell in 50 mL of enzyme-free SGF (pH 1.2) or SIF (pH 7.2) at 37°C. SIF and SGF were prepared according to the method described in the US Pharmacopeia [15] . At a specific time, the hydrogel was removed from the swelling medium and the excess s olution on the swollen sample was absorbed by gentle tamping between filter paper. The sample was weighed, and the procedure was repeated until a constant weight was achieved. The swelling ratio (Q) of hydrogels was calculated according to the expression
where Ws is the weight of the swollen hydrogel and Wd is the weight of dry hydrogel. The weights were calculated as the +SD from 3 independent experiments.
Method of Hydrolysis
The copolymers (200 mg) were poured into 5mL of SGF ( pH 1.2) or SIF ( pH 7.2). The mixture was introduced into a cellophane membrane dialysis bag. The bag was closed and transferred to a flask containing 25 mL of the same solution maintained at 37oC. The external solution was continuously stirred, and 3 mL samples were removed at selected intervals. The volume removed was replaced with SGF or SIF. Triplicate samples were used. Concentrations of 5 -ASA were determined at 300 nm for pH 1.2 and 328 nm for pH 7.2 using a 2100 Shimadzu UV-VIS spectrophotometer.
RESULTS AND DISCUSSION
Synthesis of Copolymers Having 5 -ASA Pendant Groups
MOES was prepared by direct esterification of 5-ASA with HEMA in the presence of DCC-DMAP in DMF solution. When hydrophilic polymers containing methacryloyloxyethyl-type monomers are to be prepared, copolymerization with water-soluble monomers is one possible approach. In the present case, MOES and PEGMA were copolymerized with MAA in the presence of benzoyl peroxide as an initiator at 60°C for 6 hours in methanol after degassing in a sealed tube (Scheme 1). When the water-soluble monomers (PEGMA and MAA) were rich in the feed, a water-swellable graft copolymer resulted. When the hydrophobic monomer (MOES) was rich in the feed, the resulting copolymers were well dispersed in water and methanol.
An increase in the amount of MAA in the feed ratio produces water-soluble copolymers that were, however, not collected due to their solubility under the present conditions. Table 1 shows that samples 2, 3, and 4 produced water-swellable hydrogels with a varying amount of drug-linked monomer in the copolymer composition and that sample 1 was soluble in SIF.
pH-Sensitive Swelling Studies
The equilibrium swelling ratio, Q, defined as the volume of the equilibrium swollen gel divided by the volume of the same gel before swelling, was found to be influenced by pH (Figure 1) . At the low pH of SGF (pH 1.2), the hydrogels were un-ionized and the swelling ratio was low (relevant values of Q for samples 1P-4P were 1.65, 1.22, 1.41, and 1.37 in SGF after 4 hours-presumably near-equilibrium state). At a higher pH (7.2 in SIF), the swelling reached equilibrium rapidly, which could be attributed to the higher degree of ionization (values of Q for samples 1P-4P were 3.01, 1.63, 2.22, and 1.46 in SIF after 4 hours). The equilibrium swelling was dependent on the content of carboxylic acid groups and the content of hydrophobic monomer (MOES). As shown in Figure 1 , an increase in the content of MAA groups resulted in less swelling in SGF but greater swelling in SIF. In a previous study, we reported the synthesis and swelling properties of poly (MOES-co-MAA) units [14] in which the weight percent of MAA units in the copolymer was similar to that of sample 1P.
The value of Q was about 1.34 for poly (MOES-co-MAA) and about 1.4 for sample 1P at pH 1.2. In SIF (pH 7.2), the equilibrium swelling ratio of poly (MOES-co-MAA) was 1.4 compared with the swelling ratio of 3.01 for sample 1P.
These results indicate that the incorporation of hydrophilic PEG units increases the swelling ratio in SIF (pH 7.2) but has an inverse effect in SGF (pH 1.2). It seems that hydrogen-bonded complexes may form between the PEG and MAA units of the hydrogel under acidic conditions. Consequently, the hydrogels exhibit a relatively low degree of swelling in SGF. Furthermore, the insoluble hydrogel formed in SGF dissolves in the presence of ethanol or methanol because the complexation bonds are weakened. The hydrogel exhibits a high degree of swelling in SIF (Figure 1B) , which could be related to the break of a hydrogen-bonded complex between MAA and PEG units.
As shown in Figure 1B , the swelling ratio was higher for the MAA composition (1P) in SIF. It is of interest to note that the equilibrium swelling ratio of 1P was reached after about 4 hours and that beyond this time the copolymer dissolved. After about 4 hours, it was observed that the size of hydrogel was reduced over time, indicating that dissolution was occurring. Figure 2 shows the release profiles of hydrogels at 37°C in SGF (Figure 2A ) and SIF ( Figure 2B ) as a function of time. As shown in this figure, the drug release proceeds more efficiently at a higher pH (SIF). Furthermore, increasing content of the MAA units in copolymer enhances the rate of drug release in SIF but has essentially no effect on SGF. The percentage of 5-ASA released from sample 1P was about 27.5%, and it was only 8% from sample 4P after 24 hours in SIF ( Figure 2B ). In comparison, only 12% and 8% of the drug was released after 24 hours in SGF from samples 1P and 4P, respectively.
Drug Release Studies
